APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

HMO Infant Formula

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global HMO Infant Formula Market Outlook and Growth Opportunities 2026

Report ID 17344199046 January 2026199 pages

Choose your research edition.

Industry ResearchHMO Infant Formula Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal HMO Infant Formula Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal HMO Infant Formula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HMO Infant Formula Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal HMO Infant Formula Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global HMO Infant Formula market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for HMO Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for HMO Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HMO Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the HMO Infant Formula market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the HMO Infant Formula market include Abbott, Mead Johnson（Reckitt）, Nestlé（Wyeth Nutrition）, Danone (Aptamil), FrieslandCampina (Friso), Biostime and Yili Group (Ausnutria Dairy), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global HMO Infant Formula market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of HMO Infant Formula and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents HMO Infant Formula sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the HMO Infant Formula market size, projected growth trends, production technologies, key applications, and end-use industries.

HMO Infant Formula Segment by Company

Abbott

Mead Johnson（Reckitt）

Nestlé（Wyeth Nutrition）

Danone (Aptamil)

FrieslandCampina (Friso)

Biostime

Yili Group (Ausnutria Dairy)

HMO Infant Formula Segment by Type

2'-Fucosyllactose (2'-FL)

Others

HMO Infant Formula Segment by Application

Online Channel

Specialty Store

Supermarket

Others

HMO Infant Formula Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global HMO Infant Formula status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions HMO Infant Formula market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify HMO Infant Formula significant trends, drivers, influence factors in global and regions.

6. To analyze HMO Infant Formula competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HMO Infant Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HMO Infant Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HMO Infant Formula.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the HMO Infant Formula market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global HMO Infant Formula industry.

Chapter 3: Detailed analysis of HMO Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of HMO Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of HMO Infant Formula in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. HMO Infant Formula Industry Trends Table 2. HMO Infant Formula Industry Drivers Table 3. HMO Infant Formula Industry Opportunities and Challenges Table 4. HMO Infant Formula Industry Restraints Table 5. Global HMO Infant Formula Revenue by Company (US$ Million) & (2021-2026) Table 6. Global HMO Infant Formula Revenue Share by Company (2021-2026) Table 7. Global HMO Infant Formula Sales Volume by Company (t) & (2021-2026) Table 8. Global HMO Infant Formula Sales Volume Share by Company (2021-2026) Table 9. Global HMO Infant Formula Average Price (USD/kg) of Company (2021-2026) Table 10. Global HMO Infant Formula Company Ranking, (2024-2026) & (USD Million) Table 11. Global HMO Infant Formula Key Company Manufacturing Base & Headquarters Table 12. Global HMO Infant Formula Company, Product Type & Application Table 13. Global HMO Infant Formula Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global HMO Infant Formula by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 2'-Fucosyllactose (2'-FL) Table 18. Significant Companies of Others Table 19. Global HMO Infant Formula Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global HMO Infant Formula Sales Volume by Type (2021-2026) & (t) Table 21. Global HMO Infant Formula Sales Volume by Type (2027-2032) & (t) Table 22. Global HMO Infant Formula Sales Volume Share by Type (2021-2026) Table 23. Global HMO Infant Formula Sales Volume Share by Type (2027-2032) Table 24. Global HMO Infant Formula Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global HMO Infant Formula Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global HMO Infant Formula Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global HMO Infant Formula Sales Value Share by Type (2021-2026) Table 28. Global HMO Infant Formula Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Online Channel Table 30. Significant Companies of Specialty Store Table 31. Significant Companies of Supermarket Table 32. Significant Companies of Others Table 33. Global HMO Infant Formula Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 34. Global HMO Infant Formula Sales Volume by Application (2021-2026) & (t) Table 35. Global HMO Infant Formula Sales Volume by Application (2027-2032) & (t) Table 36. Global HMO Infant Formula Sales Volume Share by Application (2021-2026) Table 37. Global HMO Infant Formula Sales Volume Share by Application (2027-2032) Table 38. Global HMO Infant Formula Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global HMO Infant Formula Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global HMO Infant Formula Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global HMO Infant Formula Sales Value Share by Application (2021-2026) Table 42. Global HMO Infant Formula Sales Value Share by Application (2027-2032) Table 43. Global HMO Infant Formula Sales by Region: 2021 VS 2025 VS 2032 (t) Table 44. Global HMO Infant Formula Sales by Region (2021-2026) & (t) Table 45. Global HMO Infant Formula Sales Market Share by Region (2021-2026) Table 46. Global HMO Infant Formula Sales by Region (2027-2032) & (t) Table 47. Global HMO Infant Formula Sales Market Share by Region (2027-2032) Table 48. Global HMO Infant Formula Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global HMO Infant Formula Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global HMO Infant Formula Sales Value Share by Region (2021-2026) Table 51. Global HMO Infant Formula Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global HMO Infant Formula Sales Value Share by Region (2027-2032) Table 53. Global HMO Infant Formula Market Average Price (USD/kg) by Region (2021-2026) Table 54. Global HMO Infant Formula Market Average Price (USD/kg) by Region (2027-2032) Table 55. Global HMO Infant Formula Sales by Country: 2021 VS 2025 VS 2032 (t) Table 56. Global HMO Infant Formula Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global HMO Infant Formula Sales by Country (2021-2026) & (t) Table 58. Global HMO Infant Formula Sales Market Share by Country (2021-2026) Table 59. Global HMO Infant Formula Sales by Country (2027-2032) & (t) Table 60. Global HMO Infant Formula Sales Market Share by Country (2027-2032) Table 61. Global HMO Infant Formula Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global HMO Infant Formula Sales Value Market Share by Country (2021-2026) Table 63. Global HMO Infant Formula Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global HMO Infant Formula Sales Value Market Share by Country (2027-2032) Table 65. Abbott Company Information Table 66. Abbott Business Overview Table 67. Abbott HMO Infant Formula Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 68. Abbott HMO Infant Formula Product Portfolio Table 69. Abbott Recent Development Table 70. Mead Johnson（Reckitt） Company Information Table 71. Mead Johnson（Reckitt） Business Overview Table 72. Mead Johnson（Reckitt） HMO Infant Formula Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 73. Mead Johnson（Reckitt） HMO Infant Formula Product Portfolio Table 74. Mead Johnson（Reckitt） Recent Development Table 75. Nestlé（Wyeth Nutrition） Company Information Table 76. Nestlé（Wyeth Nutrition） Business Overview Table 77. Nestlé（Wyeth Nutrition） HMO Infant Formula Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 78. Nestlé（Wyeth Nutrition） HMO Infant Formula Product Portfolio Table 79. Nestlé（Wyeth Nutrition） Recent Development Table 80. Danone (Aptamil) Company Information Table 81. Danone (Aptamil) Business Overview Table 82. Danone (Aptamil) HMO Infant Formula Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 83. Danone (Aptamil) HMO Infant Formula Product Portfolio Table 84. Danone (Aptamil) Recent Development Table 85. FrieslandCampina (Friso) Company Information Table 86. FrieslandCampina (Friso) Business Overview Table 87. FrieslandCampina (Friso) HMO Infant Formula Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 88. FrieslandCampina (Friso) HMO Infant Formula Product Portfolio Table 89. FrieslandCampina (Friso) Recent Development Table 90. Biostime Company Information Table 91. Biostime Business Overview Table 92. Biostime HMO Infant Formula Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 93. Biostime HMO Infant Formula Product Portfolio Table 94. Biostime Recent Development Table 95. Yili Group (Ausnutria Dairy) Company Information Table 96. Yili Group (Ausnutria Dairy) Business Overview Table 97. Yili Group (Ausnutria Dairy) HMO Infant Formula Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 98. Yili Group (Ausnutria Dairy) HMO Infant Formula Product Portfolio Table 99. Yili Group (Ausnutria Dairy) Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. HMO Infant Formula Distributors List Table 103. HMO Infant Formula Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. HMO Infant Formula Product Image Figure 2. Global HMO Infant Formula Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HMO Infant Formula Sales Value (2021-2032) & (US$ Million) Figure 4. Global HMO Infant Formula Sales (2021-2032) & (t) Figure 5. Global HMO Infant Formula Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global HMO Infant Formula Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 2'-Fucosyllactose (2'-FL) Image Figure 10. Others Image Figure 11. Global HMO Infant Formula Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global HMO Infant Formula Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global HMO Infant Formula Sales Volume Share by Type (2021-2032) Figure 14. Global HMO Infant Formula Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global HMO Infant Formula Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global HMO Infant Formula Sales Value Share by Type (2021-2032) Figure 17. Online Channel Image Figure 18. Specialty Store Image Figure 19. Supermarket Image Figure 20. Others Image Figure 21. Global HMO Infant Formula Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global HMO Infant Formula Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global HMO Infant Formula Sales Volume Share by Application (2021-2032) Figure 24. Global HMO Infant Formula Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global HMO Infant Formula Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global HMO Infant Formula Sales Value Share by Application (2021-2032) Figure 27. Global HMO Infant Formula Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 28. Global HMO Infant Formula Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global HMO Infant Formula Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global HMO Infant Formula Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America HMO Infant Formula Sales Value (2021-2032) & (US$ Million) Figure 32. North America HMO Infant Formula Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe HMO Infant Formula Sales Value (2021-2032) & (US$ Million) Figure 34. Europe HMO Infant Formula Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific HMO Infant Formula Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific HMO Infant Formula Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America HMO Infant Formula Sales Value (2021-2032) & (US$ Million) Figure 38. South America HMO Infant Formula Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa HMO Infant Formula Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa HMO Infant Formula Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt HMO Infant Formula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt HMO Infant Formula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt HMO Infant Formula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. HMO Infant Formula Value Chain Figure 126. Manufacturing Cost Structure Figure 127. HMO Infant Formula Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 2'-Fucosyllactose (2'-FL)
  • Others
Applications
  • Online Channel
  • Specialty Store
  • Supermarket
  • Others
Companies covered
  • Abbott
  • Mead Johnson（Reckitt）
  • Nestlé（Wyeth Nutrition）
  • Danone (Aptamil)
  • FrieslandCampina (Friso)
  • Biostime
  • Yili Group (Ausnutria Dairy)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global HMO Infant Formula Sales Value (2021-2032)
  4. 1.2.2 Global HMO Infant Formula Sales Volume (2021-2032)
  5. 1.2.3 Global HMO Infant Formula Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 HMO Infant Formula Market Dynamics
  1. 2.1 HMO Infant Formula Industry Trends
  2. 2.2 HMO Infant Formula Industry Drivers
  3. 2.3 HMO Infant Formula Industry Opportunities and Challenges
  4. 2.4 HMO Infant Formula Industry Restraints
3 HMO Infant Formula Market by Company
  1. 3.1 Global HMO Infant Formula Company Revenue Ranking in 2025
  2. 3.2 Global HMO Infant Formula Revenue by Company (2021-2026)
  3. 3.3 Global HMO Infant Formula Sales Volume by Company (2021-2026)
  4. 3.4 Global HMO Infant Formula Average Price by Company (2021-2026)
  5. 3.5 Global HMO Infant Formula Company Ranking (2024-2026)
  6. 3.6 Global HMO Infant Formula Company Manufacturing Base and Headquarters
  7. 3.7 Global HMO Infant Formula Company Product Type and Application
  8. 3.8 Global HMO Infant Formula Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global HMO Infant Formula Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 HMO Infant Formula Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 HMO Infant Formula Market by Type
  1. 4.1 HMO Infant Formula Type Introduction
  2. 4.1.1 2'-Fucosyllactose (2'-FL)
  3. 4.1.2 Others
  4. 4.2 Global HMO Infant Formula Sales Volume by Type
  5. 4.2.1 Global HMO Infant Formula Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global HMO Infant Formula Sales Volume by Type (2021-2032)
  7. 4.2.3 Global HMO Infant Formula Sales Volume Share by Type (2021-2032)
  8. 4.3 Global HMO Infant Formula Sales Value by Type
  9. 4.3.1 Global HMO Infant Formula Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global HMO Infant Formula Sales Value by Type (2021-2032)
  11. 4.3.3 Global HMO Infant Formula Sales Value Share by Type (2021-2032)
5 HMO Infant Formula Market by Application
  1. 5.1 HMO Infant Formula Application Introduction
  2. 5.1.1 Online Channel
  3. 5.1.2 Specialty Store
  4. 5.1.3 Supermarket
  5. 5.1.4 Others
  6. 5.2 Global HMO Infant Formula Sales Volume by Application
  7. 5.2.1 Global HMO Infant Formula Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global HMO Infant Formula Sales Volume by Application (2021-2032)
  9. 5.2.3 Global HMO Infant Formula Sales Volume Share by Application (2021-2032)
  10. 5.3 Global HMO Infant Formula Sales Value by Application
  11. 5.3.1 Global HMO Infant Formula Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global HMO Infant Formula Sales Value by Application (2021-2032)
  13. 5.3.3 Global HMO Infant Formula Sales Value Share by Application (2021-2032)
6 HMO Infant Formula Regional Sales and Value Analysis
  1. 6.1 Global HMO Infant Formula Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global HMO Infant Formula Sales by Region (2021-2032)
  3. 6.2.1 Global HMO Infant Formula Sales by Region: 2021-2026
  4. 6.2.2 Global HMO Infant Formula Sales by Region (2027-2032)
  5. 6.3 Global HMO Infant Formula Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global HMO Infant Formula Sales Value by Region (2021-2032)
  7. 6.4.1 Global HMO Infant Formula Sales Value by Region: 2021-2026
  8. 6.4.2 Global HMO Infant Formula Sales Value by Region (2027-2032)
  9. 6.5 Global HMO Infant Formula Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America HMO Infant Formula Sales Value (2021-2032)
  12. 6.6.2 North America HMO Infant Formula Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe HMO Infant Formula Sales Value (2021-2032)
  15. 6.7.2 Europe HMO Infant Formula Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific HMO Infant Formula Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific HMO Infant Formula Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America HMO Infant Formula Sales Value (2021-2032)
  21. 6.9.2 South America HMO Infant Formula Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa HMO Infant Formula Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa HMO Infant Formula Sales Value Share by Country, 2025 VS 2032
7 HMO Infant Formula Country-level Sales and Value Analysis
  1. 7.1 Global HMO Infant Formula Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global HMO Infant Formula Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global HMO Infant Formula Sales by Country (2021-2032)
  4. 7.3.1 Global HMO Infant Formula Sales by Country (2021-2026)
  5. 7.3.2 Global HMO Infant Formula Sales by Country (2027-2032)
  6. 7.4 Global HMO Infant Formula Sales Value by Country (2021-2032)
  7. 7.4.1 Global HMO Infant Formula Sales Value by Country (2021-2026)
  8. 7.4.2 Global HMO Infant Formula Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA HMO Infant Formula Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada HMO Infant Formula Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico HMO Infant Formula Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany HMO Infant Formula Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France HMO Infant Formula Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. HMO Infant Formula Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy HMO Infant Formula Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain HMO Infant Formula Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia HMO Infant Formula Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands HMO Infant Formula Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries HMO Infant Formula Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China HMO Infant Formula Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan HMO Infant Formula Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea HMO Infant Formula Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India HMO Infant Formula Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia HMO Infant Formula Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia HMO Infant Formula Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil HMO Infant Formula Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina HMO Infant Formula Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile HMO Infant Formula Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia HMO Infant Formula Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru HMO Infant Formula Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia HMO Infant Formula Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel HMO Infant Formula Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE HMO Infant Formula Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey HMO Infant Formula Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran HMO Infant Formula Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt HMO Infant Formula Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt HMO Infant Formula Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt HMO Infant Formula Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott HMO Infant Formula Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott HMO Infant Formula Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Mead Johnson（Reckitt）
  8. 8.2.1 Mead Johnson（Reckitt） Company Information
  9. 8.2.2 Mead Johnson（Reckitt） Business Overview
  10. 8.2.3 Mead Johnson（Reckitt） HMO Infant Formula Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Mead Johnson（Reckitt） HMO Infant Formula Product Portfolio
  12. 8.2.5 Mead Johnson（Reckitt） Recent Developments
  13. 8.3 Nestlé（Wyeth Nutrition）
  14. 8.3.1 Nestlé（Wyeth Nutrition） Company Information
  15. 8.3.2 Nestlé（Wyeth Nutrition） Business Overview
  16. 8.3.3 Nestlé（Wyeth Nutrition） HMO Infant Formula Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Nestlé（Wyeth Nutrition） HMO Infant Formula Product Portfolio
  18. 8.3.5 Nestlé（Wyeth Nutrition） Recent Developments
  19. 8.4 Danone (Aptamil)
  20. 8.4.1 Danone (Aptamil) Company Information
  21. 8.4.2 Danone (Aptamil) Business Overview
  22. 8.4.3 Danone (Aptamil) HMO Infant Formula Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Danone (Aptamil) HMO Infant Formula Product Portfolio
  24. 8.4.5 Danone (Aptamil) Recent Developments
  25. 8.5 FrieslandCampina (Friso)
  26. 8.5.1 FrieslandCampina (Friso) Company Information
  27. 8.5.2 FrieslandCampina (Friso) Business Overview
  28. 8.5.3 FrieslandCampina (Friso) HMO Infant Formula Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 FrieslandCampina (Friso) HMO Infant Formula Product Portfolio
  30. 8.5.5 FrieslandCampina (Friso) Recent Developments
  31. 8.6 Biostime
  32. 8.6.1 Biostime Company Information
  33. 8.6.2 Biostime Business Overview
  34. 8.6.3 Biostime HMO Infant Formula Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Biostime HMO Infant Formula Product Portfolio
  36. 8.6.5 Biostime Recent Developments
  37. 8.7 Yili Group (Ausnutria Dairy)
  38. 8.7.1 Yili Group (Ausnutria Dairy) Company Information
  39. 8.7.2 Yili Group (Ausnutria Dairy) Business Overview
  40. 8.7.3 Yili Group (Ausnutria Dairy) HMO Infant Formula Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Yili Group (Ausnutria Dairy) HMO Infant Formula Product Portfolio
  42. 8.7.5 Yili Group (Ausnutria Dairy) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 HMO Infant Formula Value Chain Analysis
  2. 9.1.1 HMO Infant Formula Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 HMO Infant Formula Sales Mode & Process
  6. 9.2 HMO Infant Formula Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 HMO Infant Formula Distributors
  9. 9.2.3 HMO Infant Formula Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst